Literature DB >> 21997468

Modeling red blood cell survival data.

Julia Korell1, Frederiek E Vos, Carolyn V Coulter, John B Schollum, Robert J Walker, Stephen B Duffull.   

Abstract

Anaemia of chronic kidney disease (CKD) is a common complication in patients with renal impairment, especially in end-stage renal failure. As well as erythropoietin deficiency, decreased red blood cell survival is a contributing factor. However, it remains unclear which mechanism underlies the altered survival of red blood cells (RBCs). In this work a previously developed statistical model for RBC survival was applied to clinical data obtained from 14 patients with CKD undergoing hemodialysis as well as 14 healthy controls using radioactive chromium (⁵¹Cr) as random labelling method. A classical two-stage approach and a full population analysis were applied to estimate the key parameters controlling random destruction and senescence in the model. Estimating random destruction was preferred over estimating an accelerated senescence in both approaches and both groups as it provided the better fit to the data. Due to significant nonspecific random loss of the label from the cells that cannot be quantified directly only a relative RBC survival can be obtained from data using ⁵¹Cr as labelling method. Nevertheless, RBC survival was found to be significantly reduced in CKD patients compared to the controls with a relative reduction of 20-30% depending on the analysis method used.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997468     DOI: 10.1007/s10928-011-9220-6

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  34 in total

1.  Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation.

Authors:  Frans L A Willekens; Bregt Roerdinkholder-Stoelwinder; Yvonne A M Groenen-Döpp; Harry J Bos; Giel J C G M Bosman; Annegeet G van den Bos; Arie J Verkleij; Jan M Werre
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

2.  The red cell chromium elution rate in patients with some hematologic diseases.

Authors:  M J CLINE; N I BERLIN
Journal:  Blood       Date:  1963-01       Impact factor: 22.113

3.  The anemia of renal failure.

Authors:  J F DESFORGES; J P DAWSON
Journal:  AMA Arch Intern Med       Date:  1958-02

4.  Recommended methods for radioisotope platelet survival studies: by the panel on Diagnostic Application of Radioisotopes in Hematology, International Committee for Standardization in Hematology.

Authors: 
Journal:  Blood       Date:  1977-12       Impact factor: 22.113

5.  An ignored error in the mathematical formulation of erythrocyte survival curves.

Authors:  V Znojil
Journal:  J Theor Biol       Date:  1983-06-21       Impact factor: 2.691

6.  REDCE: a computer program for the analysis of red cell survival data.

Authors:  F Bonomi; M Stefanelli
Journal:  Comput Programs Biomed       Date:  1980-12

7.  The prevalence of anemia in patients with chronic kidney disease.

Authors:  William McClellan; Stephen L Aronoff; W Kline Bolton; Sally Hood; Daniel L Lorber; K Linda Tang; Thomas F Tse; Brian Wasserman; Marc Leiserowitz
Journal:  Curr Med Res Opin       Date:  2004-09       Impact factor: 2.580

8.  Erythropoietin and anemia in chronic renal failure.

Authors:  V Pavlović-Kentera; G K Clemons; L Djukanović; L Biljanović-Paunovic
Journal:  Exp Hematol       Date:  1987-08       Impact factor: 3.084

9.  Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep.

Authors:  Kevin J Freise; John A Widness; Robert L Schmidt; Peter Veng-Pedersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-06-14       Impact factor: 2.745

10.  Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO).

Authors:  Sukyung Woo; Wojciech Krzyzanski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-10-18       Impact factor: 2.410

View more
  9 in total

1.  A semi-mechanistic red blood cell survival model provides some insight into red blood cell destruction mechanisms.

Authors:  Julia Korell; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-06-18       Impact factor: 2.745

2.  Age-structured population model of cell survival.

Authors:  Wojciech Krzyzanski; Pawel Wiczling; Asfiha Gebre
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-03-29       Impact factor: 2.745

3.  Modeling of red blood cell life-spans in hematologically normal populations.

Authors:  Rocío Lledó-García; Robert M Kalicki; Dominik E Uehlinger; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-07-31       Impact factor: 2.745

4.  Application of Reticulocyte-Based Estimation of Red Blood Cell Lifespan in Anemia Management of End-Stage Renal Disease Patients.

Authors:  Ly Minh Nguyen; Calvin J Meaney; Gauri G Rao; Mandip Panesar; Wojciech Krzyzanski
Journal:  AAPS J       Date:  2020-02-03       Impact factor: 4.009

5.  Reticulocyte-based estimation of red blood cell lifespan.

Authors:  Wojciech Krzyzanski; Michael E Brier; Timothy M Creed; Adam E Gaweda
Journal:  Exp Hematol       Date:  2013-05-24       Impact factor: 3.084

6.  Models for the red blood cell lifespan.

Authors:  Rajiv P Shrestha; Joseph Horowitz; Christopher V Hollot; Michael J Germain; John A Widness; Donald M Mock; Peter Veng-Pedersen; Yossi Chait
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-04-02       Impact factor: 2.745

7.  A Novel Physiology-Based Mathematical Model to Estimate Red Blood Cell Lifespan in Different Human Age Groups.

Authors:  Guohua An; John A Widness; Donald M Mock; Peter Veng-Pedersen
Journal:  AAPS J       Date:  2016-05-23       Impact factor: 4.009

8.  Erythropoietin reduces storage lesions and decreases apoptosis indices in blood bank red blood cells.

Authors:  Oscar Andrés Penuela; Fernando Palomino; Lina Andrea Gómez
Journal:  Rev Bras Hematol Hemoter       Date:  2015-11-27

9.  Population Pharmacodynamic Modeling of Epoetin Alfa in End-Stage Renal Disease Patients Receiving Maintenance Treatment Using Bayesian Approach.

Authors:  Ly Minh Nguyen; Calvin J Meaney; Gauri G Rao; Mandip Panesar; Wojciech Krzyzanski
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.